Read More Analyst Ratings News Price Target EF Hutton Maintains Buy on Generation Income, Lowers Price Target to $7 By Benzinga Newsdesk November 16, 8:43 AM EF Hutton analyst Gaurav Mehta maintains Generation Income (NASDAQ:GIPR) with a Buy and lowers the price target from $8 to $7. GIPR
Read More Earnings Equities General Guidance Health Care Movers News Trading Ideas Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024 By Vandana Singh May 9, 2:24 PM GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook. GDRX
Read More Contracts News Aerojet Rocketdyne Awarded $215.6M To Supplement Ongoing Modernization Efforts And Increase Solid Rocket Motor Manufacturing Capacity By Happy Mohamed April 14, 3:58 PM Aerojet Rocketdyne has entered into a $215.6 million Cooperative Agreement with the Defense Department to increase domestic rocket propulsion manufacturing capacity to meet increased warfighter demand for AJRD
Read More Cannabis Financing Markets News Retail Sales Cannabis Retail Giant Raises CA$30M In New Financing Program, What’s Next? By Jelena Martinovic September 1, 9:37 AM High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA) has secured CA$ 30 million in financing via an at-the-market equity offering program. HITI